The Future of Health Data: Where Are We Now and Where Are We Going?

2020 Future of Health Summit

The Future of Health Data: Where Are We Now and Where Are We Going?



December 9 at 10:30 am PT/1:30 pm ET


New players using new technologies are entering the health care space, acquiring patient data that is more in demand than ever. Health datasets are leveraged to develop tools for diagnosis, monitoring, tracking, and reporting of illnesses. There are myriad new applications, especially in the context of COVID-19. However, reports of data breaches and mismanagement have engendered a lack of trust and an adverse view of many entities that acquire and analyze health data. Use of outdated or poorly gathered non-representative health datasets may raise a risk of disparities in care if the algorithms based on such datasets are applied in real-world settings. When health technology is booming, it is essential to identify the steps required to promote equity in the collection of health-related data. Experts will discuss the effects and implications of current practices and evaluate approaches to ensure that new technologies advance biomedical research through equitable data collection.


Andrea Coravos
Co-Founder and CEO, Elektra Labs

James Golden
CEO, WorldQuant Predictive

Alaa Halawa
Co-Head, US Ventures, Mubadala Capital

Richard Merkin
CEO, The Heritage Group; Founder, Richard Merkin Foundation for Stem Cell Research

Don Rucker
National Coordinator for Health Information Technology, US Department of Health and Human Services


Jon Fortt
Co-Anchor, Squawk Alley, CNBC

See Also

Data Collection and Use During COVID-19

Cures for Life: Long-Term Follow-Up Data Collection for Cell and Gene Therapies

Published December 9, 2020